Aggressive blood cancer: A key protein could pave the way for targeted therapies
Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have improved outcomes for some ...
Jun 25, 2025
0
39









